Literature DB >> 34060546

Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges.

Jaime Castillo-León1, Ramona Trebbien2, John J Castillo3, Winnie E Svendsen1.   

Abstract

The ongoing COVID-19 pandemic has shown the importance of having analytical devices that allow a simple, fast, and robust detection of pathogens which cause epidemics and pandemics. The information these devices can collect is crucial for health authorities to make effective decisions to contain the disease's advance. The World Health Organization published a list of primary pathogens that have raised concern as potential causes of future pandemics. Unfortunately, there are no rapid diagnostic tests commercially available and approved by the regulatory bodies to detect most of the pathogens listed by the WHO. This report describes these pathogens, the available detection methods, and highlights areas where more attention is needed to produce rapid diagnostic tests for future pandemic surveillance.

Entities:  

Year:  2021        PMID: 34060546     DOI: 10.1039/d0an02286a

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  2 in total

Review 1.  Rapid diagnostic tests versus RT-PCR for Ebola virus infections: a systematic review and meta-analysis.

Authors:  Basilua Andre Muzembo; Kei Kitahara; Ayumu Ohno; Ngangu Patrick Ntontolo; Nlandu Roger Ngatu; Keinosuke Okamoto; Shin-Ichi Miyoshi
Journal:  Bull World Health Organ       Date:  2022-06-01       Impact factor: 13.831

2.  Performance Validation of COVID-19 Self-Conduct Buccal and Nasal Swabs RTK-Antigen Diagnostic Kit.

Authors:  Mohammad Nur Amin Kalil; Wardah Yusof; Naveed Ahmed; Mohd Hashairi Fauzi; Mimi Azliha Abu Bakar; Afifah Sjamun Sjahid; Rosline Hassan; Chan Yean Yean
Journal:  Diagnostics (Basel)       Date:  2021-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.